{
    "Trade/Device Name(s)": [
        "VITEK 2 AST-Gram Negative Imipenem/Relebactam",
        "VITEK 2 AST-GN Imipenem/Relebactam",
        "VITEK 2 AST-Gram Negative Imipenem/Relebactam (\u22640.25/4 - \u226516/4 \u03bcg/mL)"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K211136",
    "Predicate Device Reference 510(k) Number(s)": [
        "K193572"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTW",
        "LTT"
    ],
    "Summary Letter Date": "April 15, 2021",
    "Summary Letter Received Date": "April 16, 2021",
    "Submission Date": "April 8, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Imipenem/Relebactam susceptibility for Gram-negative bacilli"
    ],
    "Specimen Type(s)": [
        "Clinical isolate of aerobic Gram-negative bacilli"
    ],
    "Specimen Container(s)": [
        "Saline suspension",
        "VITEK 2 AST-GN card"
    ],
    "Instrument(s)/Platform(s)": [
        "VITEK 2",
        "VITEK 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated microdilution antimicrobial susceptibility testing"
    ],
    "Methodologies": [
        "Microdilution minimum inhibitory concentration (MIC) technique",
        "Automated susceptibility growth analysis"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Susceptibility card",
        "Automated system"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-Gram Negative Imipenem/Relebactam susceptibility card for automated MIC testing of Gram-negative bacilli on VITEK 2 platforms",
    "Indications for Use Summary": "Designed for antimicrobial susceptibility testing of Gram-negative bacilli in clinical laboratories using VITEK 2 systems, reporting quantitative Imipenem/Relebactam MIC values for organisms including Acinetobacter calcoaceticus-baumannii complex, Klebsiella aerogenes, Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Citrobacter freundii, Klebsiella oxytoca, and others.",
    "fda_folder": "Microbiology"
}